Faheem Hasnain, Director at Mirati Therapeutics, Inc. (MRTX), bought 21,582 shares at $27.80 ($600K) on 2023-08-11, disclosed to the SEC on 2023-08-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.80 | 10,791 | $300K | 50.0% |
| 2 | $27.80 | 10,791 | $300K | 50.0% |
| Total | $27.80 avg | 21,582 | $600K | 100% |
| Filing → |
| GOSS | BUY | 2024-06-24 | $498K | — | Filing → |
| GOSS | SELL | 2024-03-28 | $27K | — | Filing → |
| GOSS | BUY | 2023-03-22 | $2.0M | — | Filing → |